当前位置: 首页 >> 检索结果
7550. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
作者: Brian Hutton.;Georgia Salanti.;Deborah M Caldwell.;Anna Chaimani.;Christopher H Schmid.;Chris Cameron.;John P A Ioannidis.;Sharon Straus.;Kristian Thorlund.;Jeroen P Jansen.;Cynthia Mulrow.;Ferrán Catalá-López.;Peter C Gøtzsche.;Kay Dickersin.;Isabelle Boutron.;Douglas G Altman.;David Moher.
来源: Ann Intern Med. 2015年162卷11期777-84页
The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives. With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-to-face discussion and consensus meeting to establish new checklist items for this extension statement. Current PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.
7551. Revisit rates and associated costs after an emergency department encounter: a multistate analysis.
作者: Reena Duseja.;Naomi S Bardach.;Grace A Lin.;Jinoos Yazdany.;Mitzi L Dean.;Theodore H Clay.;W John Boscardin.;R Adams Dudley.
来源: Ann Intern Med. 2015年162卷11期750-6页
Return visits to the emergency department (ED) or hospital after an index ED visit strain the health system, but information about rates and determinants of revisits is limited.
7552. Differences between early and late readmissions among patients: a cohort study.
作者: Kelly L Graham.;Elissa H Wilker.;Michael D Howell.;Roger B Davis.;Edward R Marcantonio.
来源: Ann Intern Med. 2015年162卷11期741-9页
Early and late readmissions may have different causal factors, requiring different prevention strategies.
7553. Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis.
作者: Frederick A Spencer.;Manya Prasad.;Per O Vandvik.;Devin Chetan.;Qi Zhou.;Gordon Guyatt.
来源: Ann Intern Med. 2015年163卷2期118-26页
The appropriate duration of dual-antiplatelet therapy (DAPT) after drug-eluting stent (DES) placement remains controversial.
7554. Active Tracing and Monitoring of Contacts Associated With the First Cluster of Ebola in the United States.
作者: Wendy M Chung.;Jessica C Smith.;Lauren M Weil.;Sonya M Hughes.;Sibeso N Joyner.;Emily M Hall.;Julia Ritch.;Divya Srinath.;Edward Goodman.;Michelle S Chevalier.;Lauren Epstein.;Jennifer C Hunter.;Alexander J Kallen.;Mateusz P Karwowski.;David T Kuhar.;Charnetta Smith.;Lyle R Petersen.;Barbara E Mahon.;David L Lakey.;Stephanie J Schrag.
来源: Ann Intern Med. 2015年163卷3期164-73页
Following hospitalization of the first patient with Ebola virus disease diagnosed in the United States on 28 September 2014, contact tracing methods for Ebola were implemented.
|